OBJECTIVE: to create a method for assessing physician performance and care outcomes that are adjusted for procedure acuity and patient comorbidity. DESIGN: between 2004 and 2008 surgical procedures performed by 10 surgeons were stratified into high-acuity procedures (HAPs) and low-acuity procedures (LAPs). Risk adjustment was made for comorbid conditions examined singly or in groups of 2 or more. SETTING: a tertiary care medical center. PATIENTS: a total of 2618 surgical patients. MAIN OUTCOME MEASURES: performance measures included length of stay; return to operating room within 7 days of surgery; and the occurrence of mortality, hospital readmission, transfusion, and wound infection within 30 days of surgery. RESULTS: the transfusion rate was 2.7% and 40.6% for LAPs and HAPs, respectively. Wound infection rates were 1.4% for LAPs vs 14.1% for HAPs, while 30-day mortality rate was 0.3% and 1.6% for LAPs and HAPs, respectively. The mean (SD) hospital stay for LAPs was 2.1 (3.6) vs 10.5 (7.0) days for HAPs. Negative performance factors were significantly higher for patients who underwent HAPs and had comorbid conditions. Differences among surgeons significantly affect the incidence of negative performance indicators. Factors affecting performance measures were procedure acuity, the surgeon, and comorbidity, in order of decreasing significance. Surgeons were ranked low, middle, and high based on negative performance indicators. CONCLUSIONS: performance measures following oncologic procedures were significantly affected by comorbid conditions and by procedure acuity. Although the latter most strongly affects quality and performance indicators, both should weigh heavily in physician comparisons. The incidence of negative performance indicators was also influenced by the individual surgeon. These data may serve as a tool to evaluate and improve physician performance and outcomes and to develop risk-adjusted benchmarks. Ultimately, reimbursement may be tied to quantifiable measures of physician and institutional performance.
OBJECTIVE: to create a method for assessing physician performance and care outcomes that are adjusted for procedure acuity and patient comorbidity. DESIGN: between 2004 and 2008 surgical procedures performed by 10 surgeons were stratified into high-acuity procedures (HAPs) and low-acuity procedures (LAPs). Risk adjustment was made for comorbid conditions examined singly or in groups of 2 or more. SETTING: a tertiary care medical center. PATIENTS: a total of 2618 surgical patients. MAIN OUTCOME MEASURES: performance measures included length of stay; return to operating room within 7 days of surgery; and the occurrence of mortality, hospital readmission, transfusion, and wound infection within 30 days of surgery. RESULTS: the transfusion rate was 2.7% and 40.6% for LAPs and HAPs, respectively. Wound infection rates were 1.4% for LAPs vs 14.1% for HAPs, while 30-day mortality rate was 0.3% and 1.6% for LAPs and HAPs, respectively. The mean (SD) hospital stay for LAPs was 2.1 (3.6) vs 10.5 (7.0) days for HAPs. Negative performance factors were significantly higher for patients who underwent HAPs and had comorbid conditions. Differences among surgeons significantly affect the incidence of negative performance indicators. Factors affecting performance measures were procedure acuity, the surgeon, and comorbidity, in order of decreasing significance. Surgeons were ranked low, middle, and high based on negative performance indicators. CONCLUSIONS: performance measures following oncologic procedures were significantly affected by comorbid conditions and by procedure acuity. Although the latter most strongly affects quality and performance indicators, both should weigh heavily in physician comparisons. The incidence of negative performance indicators was also influenced by the individual surgeon. These data may serve as a tool to evaluate and improve physician performance and outcomes and to develop risk-adjusted benchmarks. Ultimately, reimbursement may be tied to quantifiable measures of physician and institutional performance.
Authors: Andrea Sisko; Christopher Truffer; Sheila Smith; Sean Keehan; Jonathan Cylus; John A Poisal; M Kent Clemens; Joseph Lizonitz Journal: Health Aff (Millwood) Date: 2009-02-24 Impact factor: 6.301
Authors: Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko Journal: J Natl Cancer Inst Date: 2008-09-09 Impact factor: 13.506
Authors: Kristin M Gendron; Stephen Y Lai; Gregory S Weinstein; Ara A Chalian; Julian M Husbands; Patricia F Wolf; Liesje DiDonato; Randal S Weber Journal: Arch Otolaryngol Head Neck Surg Date: 2002-03
Authors: Donlin M Long; Toby Gordon; Helen Bowman; Anthony Etzel; Gregg Burleyson; Simone Betchen; Ira M Garonzik; Henry Brem Journal: Neurosurgery Date: 2003-05 Impact factor: 4.654
Authors: Karyn B Stitzenberg; Elin R Sigurdson; Brian L Egleston; Russell B Starkey; Neal J Meropol Journal: J Clin Oncol Date: 2009-08-31 Impact factor: 44.544
Authors: Evan M Graboyes; Melanie E Townsend; Dorina Kallogjeri; Jay F Piccirillo; Brian Nussenbaum Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-12-01 Impact factor: 6.223
Authors: Evan M Graboyes; Jennifer Gross; Dorina Kallogjeri; Jay F Piccirillo; Maha Al-Gilani; Michael E Stadler; Brian Nussenbaum Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-05-01 Impact factor: 6.223
Authors: Carol M Lewis; Marcus M Monroe; Dianna B Roberts; Amy C Hessel; Stephen Y Lai; Randal S Weber Journal: Cancer Date: 2015-01-13 Impact factor: 6.860
Authors: Mahmoud I Awad; Frank L Palmer; Lei Kou; Changhong Yu; Pablo H Montero; Andrew G Shuman; Ian Ganly; Jatin P Shah; Michael W Kattan; Snehal G Patel Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-11 Impact factor: 6.223
Authors: William Ross; Patrick Lynch; Gottumukkala Raju; Alma Rodriguez; Thomas Burke; Lisa Hafemeister; Ernest Hawk; Xifeng Wu; Raymond N Dubois; Lopa Mishra Journal: Genes Cancer Date: 2012-01
Authors: Jeanne L Hatcher; Katherine R Sterba; Janet A Tooze; Terry A Day; Matthew J Carpenter; Anthony J Alberg; Christopher A Sullivan; Nora C Fitzgerald; Kathryn E Weaver Journal: Head Neck Date: 2015-05-17 Impact factor: 3.147
Authors: Carol M Lewis; Thomas A Aloia; Weiming Shi; Ira Martin; Stephen Y Lai; Jesse C Selber; Amy C Hessel; Matthew M Hanasono; Katherine A Hutcheson; Geoffrey L Robb; Randal S Weber Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-04 Impact factor: 6.223
Authors: Dylan A Levy; Hong Li; Katherine R Sterba; Chanita Hughes-Halbert; Graham W Warren; Brian Nussenbaum; Anthony J Alberg; Terry A Day; Evan M Graboyes Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-05-01 Impact factor: 6.223